🔗 Share this article

The top legal official in Texas Paxton is filing a lawsuit against the makers of acetaminophen, alleging the companies concealed potential risks that the medication posed to children's cognitive development.

This legal action arrives thirty days after Former President Trump advocated an unsubstantiated connection between taking acetaminophen - referred to as paracetamol - during pregnancy and autism in young ones.

The attorney general is taking legal action against the pharmaceutical giant, which once produced the drug, the only pain reliever approved for pregnant women, and Kenvue, which now manufacturers it.

In a official comment, he claimed they "misled consumers by making money from pain and pushing pills without regard for the risks."

The manufacturer asserts there is insufficient reliable data tying acetaminophen to autism spectrum disorder.

"These manufacturers misled for generations, intentionally threatening numerous people to boost earnings," Paxton, from the Republican party, declared.

The company said in a statement that it was "deeply concerned by the dissemination of inaccurate information on the security of acetaminophen and the potential impact that could have on the well-being of US mothers and children."

On its official site, Kenvue also said it had "consistently assessed the pertinent research and there is no credible data that indicates a proven link between consuming acetaminophen and autism spectrum disorder."

Associations representing medical professionals and healthcare providers concur.

The American College of Obstetricians and Gynecologists has said paracetamol - the main ingredient in acetaminophen - is among limited choices for pregnant women to address pain and elevated temperature, which can create significant medical dangers if not addressed.

"In more than two decades of investigation on the utilization of paracetamol in pregnancy, not a single reputable study has conclusively proven that the use of acetaminophen in any period of pregnancy results in brain development issues in young ones," the association commented.

The court filing cites recent announcements from the Trump administration in arguing the medication is potentially dangerous.

Recently, the former president generated worry from public health officials when he instructed women during pregnancy to "fight like hell" not to take acetaminophen when unwell.

Federal regulators then issued a notice that physicians should contemplate reducing the consumption of Tylenol, while also stating that "a proven link" between the medication and autism in children has remains unverified.

Health Secretary Robert F Kennedy Jr, who oversees the Food and Drug Administration, had vowed in April to undertake "a massive testing and research effort" that would determine the cause of autism in a limited time.

But authorities advised that discovering a single cause of autism spectrum disorder - believed by scientists to be the consequence of a complicated interplay of genetic and environmental factors - would be difficult.

Autism is a form of lifelong neurodivergence and impairment that affects how individuals perceive and relate to the world, and is identified using physician assessments.

In his legal document, the attorney general - aligned with the former president who is campaigning for the Senate - claims the manufacturer and Johnson & Johnson "willfully ignored and sought to suppress the research" around acetaminophen and autism.

This legal action aims to force the firms "remove any marketing or advertising" that asserts acetaminophen is reliable for expectant mothers.

The Texas lawsuit parallels the grievances of a assembly of mothers and fathers of minors with autism spectrum disorder and ADHD who filed suit against the manufacturers of Tylenol in two years ago.

A federal judge threw out the legal action, saying investigations from the parents' expert witnesses was inconclusive.